日本數位病理市場報告（按產品、類型、交付模式、應用、最終用戶和地區分類，2026-2034年）

2025年，日本數位病理市場規模達4,620萬美元。展望未來， IMARC Group預計到2034年，該市場規模將達到1.301億美元，2026年至2034年期間的複合年成長率（CAGR）為12.18%。主要醫療技術企業在醫療保健技術領域的廣泛投資是推動市場成長的主要因素。

本報告解答的關鍵問題：

• 日本數位病理市場目前的表現如何？未來幾年又將如何發展？
• 新冠疫情對日本數位病理市場產生了哪些影響？
• 日本數位病理市場依產品分類的組成是怎樣的？
• 日本數位病理市場按類型分類的組成是怎樣的？
• 日本數位病理市場按服務模式分類的組成是怎樣的？
• 日本數位病理市場按應用領域分類的組成是怎樣的？
• 日本數位病理市場以最終用戶分類的組成是怎樣的？
• 日本數位病理市場價值鏈的各個階段有哪些？
• 日本數位病理學的關鍵促進因素和挑戰是什麼？
• 日本數位病理市場的結構是怎麼樣的？主要參與者有哪些？
• 日本數位病理學市場的競爭程度如何？

目錄

第1章：序言

第2章：範圍與方法

• 研究目標
• 利害關係人
• 數據來源
• 市場估算
• 預測方法

第3章：執行概要

第4章：日本數位病理市場－簡介

• 概述
• 市場動態
• 產業趨勢
• 競爭情報

第5章：日本數位病理市場概況

• 歷史及當前市場趨勢（2020-2025）
• 市場預測（2026-2034）

第6章：日本數位病理市場－依產品細分

• 掃描儀
• 軟體
• 儲存系統
• 通訊系統

第7章：日本數位病理市場－按類型分類

• 人類病理學
• 獸醫病理學

第8章：日本數位病理市場－依交付模式分類

• 現場
• 託管

第9章：日本數位病理市場－按應用領域分類

• 培訓和教育
• 諮詢服務
• 術中會診
• 常規診斷諮詢服務
• 其他

第10章：日本數位病理市場－以最終用戶分類

• 製藥和生物技術公司
• 醫院和參考實驗室
• 學術和研究機構

第11章：日本數位病理市場－按地區分類

• 關東地區
• 關西/近畿地區
• 中部/中部地區
• 九州·沖繩地區
• 東北部地區
• 中國地區
• 北海道地區
• 四國地區

第12章：日本數位病理市場－競爭格局

• 概述
• 市場結構
• 市場參與者定位
• 最佳制勝策略
• 競爭格局分析
• 公司評估象限

第13章：關鍵參與者簡介

第14章：日本數位病理市場—產業分析

• 促進因素、限制因素和機遇
• 波特五力分析
• 價值鏈分析

第15章：附錄

Japan digital pathology market size reached USD 46.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 130.1 Million by 2034, exhibiting a growth rate (CAGR) of 12.18% during 2026-2034. The widespread investments by key players in the healthcare technologies are primarily driving the market growth.

Digital pathology is a cutting-edge medical technology that revolutionizes the traditional practice of examining tissue samples for disease diagnosis. Instead of using conventional glass slides, digital pathology involves the digitization of tissue samples into high-resolution images. These digital images are then stored, analyzed, and shared electronically, enabling pathologists and medical professionals to collaborate and make diagnoses remotely. Digital pathology offers numerous advantages, including improved accuracy, speed, and efficiency in diagnosing diseases such as cancer. It also facilitates the integration of artificial intelligence and machine learning algorithms, which can assist in automating certain aspects of image analysis and enhancing diagnostic precision. Additionally, digital pathology allows for the creation of extensive digital archives, enabling researchers to access and study a vast repository of medical data for various purposes, including medical research, education, and quality assurance in healthcare settings.

Japan Digital Pathology Market Trends:

The digital pathology market in Japan is witnessing significant growth and transformation within the country's healthcare landscape. Japan, known for its technological advancements, is embracing digital pathology as a powerful tool to enhance disease diagnosis and patient care. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses. With a growing aging population, the demand for precise and timely pathology services is increasing, making digital pathology an invaluable asset in managing healthcare needs efficiently. Additionally, the integration of artificial intelligence and machine learning into digital pathology systems is enhancing diagnostic capabilities further. These innovations not only improve diagnostic accuracy but also help address the challenges posed by a shortage of pathologists in the country. As Japan continues to invest in healthcare technologies, the digital pathology market is poised for continued growth and innovation to meet the evolving demands of the healthcare sector.

Japan Digital Pathology Market Segmentation:

Product Insights:

• Scanners
• Software
• Storage Systems
• Communication Systems

Type Insights:

• Human Pathology
• Veterinary Pathology

Delivery Model Insights:

• On-premises
• Hosted

Application Insights:

• Training and Education
• Consulting Services
• Intraoperative Consultation
• Routine Diagnostic Consultation Services
• Others

End User Insights:

• Pharmaceutical and Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic and Research Institutes

Regional Insights:

• Kanto Region
• Kansai/Kinki Region
• Central/ Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region
• The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan digital pathology market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan digital pathology market?
• What is the breakup of the Japan digital pathology market on the basis of product?
• What is the breakup of the Japan digital pathology market on the basis of type?
• What is the breakup of the Japan digital pathology market on the basis of delivery model?
• What is the breakup of the Japan digital pathology market on the basis of application?
• What is the breakup of the Japan digital pathology market on the basis of end user?
• What are the various stages in the value chain of the Japan digital pathology market?
• What are the key driving factors and challenges in the Japan digital pathology?
• What is the structure of the Japan digital pathology market and who are the key players?
• What is the degree of competition in the Japan digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Pathology Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Digital Pathology Market Landscape

• 5.1 Historical and Current Market Trends (2020-2025)
• 5.2 Market Forecast (2026-2034)

6 Japan Digital Pathology Market - Breakup by Product

• 6.1 Scanners
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2020-2025)
  • 6.1.3 Market Forecast (2026-2034)
• 6.2 Software
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2020-2025)
  • 6.2.3 Market Forecast (2026-2034)
• 6.3 Storage Systems
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2020-2025)
  • 6.3.3 Market Forecast (2026-2034)
• 6.4 Communication Systems
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2020-2025)
  • 6.4.3 Market Forecast (2026-2034)

7 Japan Digital Pathology Market - Breakup by Type

• 7.1 Human Pathology
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2020-2025)
  • 7.1.3 Market Forecast (2026-2034)
• 7.2 Veterinary Pathology
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2020-2025)
  • 7.2.3 Market Forecast (2026-2034)

8 Japan Digital Pathology Market - Breakup by Delivery Model

• 8.1 On-premises
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2020-2025)
  • 8.1.3 Market Forecast (2026-2034)
• 8.2 Hosted
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2020-2025)
  • 8.2.3 Market Forecast (2026-2034)

9 Japan Digital Pathology Market - Breakup by Application

• 9.1 Training and Education
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2020-2025)
  • 9.1.3 Market Forecast (2026-2034)
• 9.2 Consulting Services
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2020-2025)
  • 9.2.3 Market Forecast (2026-2034)
• 9.3 Intraoperative Consultation
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2020-2025)
  • 9.3.3 Market Forecast (2026-2034)
• 9.4 Routine Diagnostic Consultation Services
  • 9.4.1 Overview
  • 9.4.2 Historical and Current Market Trends (2020-2025)
  • 9.4.3 Market Forecast (2026-2034)
• 9.5 Others
  • 9.5.1 Historical and Current Market Trends (2020-2025)
  • 9.5.2 Market Forecast (2026-2034)

10 Japan Digital Pathology Market - Breakup by End User

• 10.1 Pharmaceutical and Biotechnology Companies
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2020-2025)
  • 10.1.3 Market Forecast (2026-2034)
• 10.2 Hospitals and Reference Laboratories
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2020-2025)
  • 10.2.3 Market Forecast (2026-2034)
• 10.3 Academic and Research Institutes
  • 10.3.1 Overview
  • 10.3.2 Historical and Current Market Trends (2020-2025)
  • 10.3.3 Market Forecast (2026-2034)

11 Japan Digital Pathology Market - Breakup by Region

• 11.1 Kanto Region
  • 11.1.1 Overview
  • 11.1.2 Historical and Current Market Trends (2020-2025)
  • 11.1.3 Market Breakup by Product
  • 11.1.4 Market Breakup by Type
  • 11.1.5 Market Breakup by Delivery Model
  • 11.1.6 Market Breakup by Application
  • 11.1.7 Market Breakup by End User
  • 11.1.8 Key Players
  • 11.1.9 Market Forecast (2026-2034)
• 11.2 Kansai/Kinki Region
  • 11.2.1 Overview
  • 11.2.2 Historical and Current Market Trends (2020-2025)
  • 11.2.3 Market Breakup by Product
  • 11.2.4 Market Breakup by Type
  • 11.2.5 Market Breakup by Delivery Model
  • 11.2.6 Market Breakup by Application
  • 11.2.7 Market Breakup by End User
  • 11.2.8 Key Players
  • 11.2.9 Market Forecast (2026-2034)
• 11.3 Central/Chubu Region
  • 11.3.1 Overview
  • 11.3.2 Historical and Current Market Trends (2020-2025)
  • 11.3.3 Market Breakup by Product
  • 11.3.4 Market Breakup by Type
  • 11.3.5 Market Breakup by Delivery Model
  • 11.3.6 Market Breakup by Application
  • 11.3.7 Market Breakup by End User
  • 11.3.8 Key Players
  • 11.3.9 Market Forecast (2026-2034)
• 11.4 Kyushu-Okinawa Region
  • 11.4.1 Overview
  • 11.4.2 Historical and Current Market Trends (2020-2025)
  • 11.4.3 Market Breakup by Product
  • 11.4.4 Market Breakup by Type
  • 11.4.5 Market Breakup by Delivery Model
  • 11.4.6 Market Breakup by Application
  • 11.4.7 Market Breakup by End User
  • 11.4.8 Key Players
  • 11.4.9 Market Forecast (2026-2034)
• 11.5 Tohoku Region
  • 11.5.1 Overview
  • 11.5.2 Historical and Current Market Trends (2020-2025)
  • 11.5.3 Market Breakup by Product
  • 11.5.4 Market Breakup by Type
  • 11.5.5 Market Breakup by Delivery Model
  • 11.5.6 Market Breakup by Application
  • 11.5.7 Market Breakup by End User
  • 11.5.8 Key Players
  • 11.5.9 Market Forecast (2026-2034)
• 11.6 Chugoku Region
  • 11.6.1 Overview
  • 11.6.2 Historical and Current Market Trends (2020-2025)
  • 11.6.3 Market Breakup by Product
  • 11.6.4 Market Breakup by Type
  • 11.6.5 Market Breakup by Delivery Model
  • 11.6.6 Market Breakup by Application
  • 11.6.7 Market Breakup by End User
  • 11.6.8 Key Players
  • 11.6.9 Market Forecast (2026-2034)
• 11.7 Hokkaido Region
  • 11.7.1 Overview
  • 11.7.2 Historical and Current Market Trends (2020-2025)
  • 11.7.3 Market Breakup by Product
  • 11.7.4 Market Breakup by Type
  • 11.7.5 Market Breakup by Delivery Model
  • 11.7.6 Market Breakup by Application
  • 11.7.7 Market Breakup by End User
  • 11.7.8 Key Players
  • 11.7.9 Market Forecast (2026-2034)
• 11.8 Shikoku Region
  • 11.8.1 Overview
  • 11.8.2 Historical and Current Market Trends (2020-2025)
  • 11.8.3 Market Breakup by Product
  • 11.8.4 Market Breakup by Type
  • 11.8.5 Market Breakup by Delivery Model
  • 11.8.6 Market Breakup by Application
  • 11.8.7 Market Breakup by End User
  • 11.8.8 Key Players
  • 11.8.9 Market Forecast (2026-2034)

12 Japan Digital Pathology Market - Competitive Landscape

• 12.1 Overview
• 12.2 Market Structure
• 12.3 Market Player Positioning
• 12.4 Top Winning Strategies
• 12.5 Competitive Dashboard
• 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

• 13.1 Company A
  • 13.1.1 Business Overview
  • 13.1.2 Product Portfolio
  • 13.1.3 Business Strategies
  • 13.1.4 SWOT Analysis
  • 13.1.5 Major News and Events
• 13.2 Company B
  • 13.2.1 Business Overview
  • 13.2.2 Product Portfolio
  • 13.2.3 Business Strategies
  • 13.2.4 SWOT Analysis
  • 13.2.5 Major News and Events
• 13.3 Company C
  • 13.3.1 Business Overview
  • 13.3.2 Product Portfolio
  • 13.3.3 Business Strategies
  • 13.3.4 SWOT Analysis
  • 13.3.5 Major News and Events
• 13.4 Company D
  • 13.4.1 Business Overview
  • 13.4.2 Product Portfolio
  • 13.4.3 Business Strategies
  • 13.4.4 SWOT Analysis
  • 13.4.5 Major News and Events
• 13.5 Company E
  • 13.5.1 Business Overview
  • 13.5.2 Product Portfolio
  • 13.5.3 Business Strategies
  • 13.5.4 SWOT Analysis
  • 13.5.5 Major News and Events

14 Japan Digital Pathology Market - Industry Analysis

• 14.1 Drivers, Restraints, and Opportunities
  • 14.1.1 Overview
  • 14.1.2 Drivers
  • 14.1.3 Restraints
  • 14.1.4 Opportunities
• 14.2 Porters Five Forces Analysis
  • 14.2.1 Overview
  • 14.2.2 Bargaining Power of Buyers
  • 14.2.3 Bargaining Power of Suppliers
  • 14.2.4 Degree of Competition
  • 14.2.5 Threat of New Entrants
  • 14.2.6 Threat of Substitutes
• 14.3 Value Chain Analysis

15 Appendix